Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Moleculin Biotech, Inc. (MBRX)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 10, 2026 | CORRESP | Neutral/Informational | Moderate | Moleculin Biotech, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3, originally filed on March 27, 20… | Read Filing EDGAR |
| Apr. 2, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Moleculin Biotech, Inc. that it will not review the company's registration statement filed on March 27, 2026. The SEC emphasizes that the responsibilit… | Read Filing EDGAR |
| Jan. 2, 2026 | CORRESP | Neutral/Informational | Moderate | Moleculin Biotech, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking to have it declared effec… | Read Filing EDGAR |
| Jan. 2, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has notified Moleculin Biotech, Inc. that it will not review their registration statement filed on December 23, 2025. The letter emphasizes that the responsibility for the… | Read Filing EDGAR |
| Sep. 29, 2025 | CORRESP | Neutral/Informational | Moderate | Moleculin Biotech, Inc. has submitted a request to the U.S. Securities and Exchange Commission to accelerate the effective date of their Registration Statement on Form S-3. They a… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.